These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5823458)

  • 1. Some theoretical aspects of bulk compounding technology. II. Suspensions.
    Am J Hosp Pharm; 1969 Sep; 26(9):548-50. PubMed ID: 5823458
    [No Abstract]   [Full Text] [Related]  

  • 2. Bulk compounding technology.
    Schumacher GE
    Am J Hosp Pharm; 1969 Nov; 26(11):650-2. PubMed ID: 5352573
    [No Abstract]   [Full Text] [Related]  

  • 3. The bulk compounding of technology of liquids and semi-solids.
    Schumacher GE
    Am J Hosp Pharm; 1969 Feb; 26(2):70-99. PubMed ID: 5766229
    [No Abstract]   [Full Text] [Related]  

  • 4. Bulk compounding technology.
    Schumacher GE
    Am J Hosp Pharm; 1968 Nov; 25(11):661-2. PubMed ID: 5696167
    [No Abstract]   [Full Text] [Related]  

  • 5. Some theoretical aspects of bulk compounding technology. 3. Emulsions.
    Schumacher GE
    Am J Hosp Pharm; 1970 Jan; 27(1):64-6. PubMed ID: 5411640
    [No Abstract]   [Full Text] [Related]  

  • 6. Some theoretical aspects of bulk compounding technology. I. Ionic equilibria, pH and choice of solvents.
    Am J Hosp Pharm; 1969 Jun; 26(6):354-6. PubMed ID: 5797289
    [No Abstract]   [Full Text] [Related]  

  • 7. Bulk compounding in Canadian hospitals--a survey.
    Taddio A; Wilson W
    Can J Hosp Pharm; 1990 Oct; 43(5):213-8, xxxii. PubMed ID: 10107923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulk compounding technology. The palatability of bulk compounded products. 3.
    Schumacher GE
    Am J Hosp Pharm; 1968 Mar; 25(3):154-6. PubMed ID: 5658861
    [No Abstract]   [Full Text] [Related]  

  • 9. Caution with preparing suspensions.
    Horn JR
    Am Pharm; 1994 Dec; NS34(12):4-5. PubMed ID: 7856508
    [No Abstract]   [Full Text] [Related]  

  • 10. [PREPARATION OF INJECTABLE DRUG SUSPENSIONS. I. PREPARATION OF A 2.5 O AQUEOUS SUSPENSION OF DESOXYCORTICOSTERONE TRIMETHYLACETATE].
    VOLKOVINSKAIA LP; POZHARSKAIA AM
    Med Prom SSSR; 1963 Jul; 17():42-3. PubMed ID: 14069026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preparation, hydrolysis and resorption of chloramphenicol palmitate-suspensions].
    Braeckman P; van Severen R; Dony J; de Roeck A
    Pharmazie; 1966 Dec; 21(12):757-60. PubMed ID: 6001165
    [No Abstract]   [Full Text] [Related]  

  • 12. Bulk compounding technology.
    Schumacher GE
    Am J Hosp Pharm; 1966 Nov; 23(11):628-9. PubMed ID: 5979854
    [No Abstract]   [Full Text] [Related]  

  • 13. Bulk compounding technology.
    Schumacher GE
    Am J Hosp Pharm; 1965 Oct; 22(10):580-1 concl. PubMed ID: 5826561
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of manufacturing conditions and physical properties of sulfonamide and palmitate suspensions of chloramphenicol on their stability and resorption].
    Moës A
    Mem Acad R Med Belg; 1969; 5(6):797-899. PubMed ID: 5360537
    [No Abstract]   [Full Text] [Related]  

  • 15. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Standard prescriptions for the formulation of medicinal preparations in pharmacies. I. Suspensions for dermal administration].
    Subert J; Kolár J; Vasková V
    Ceska Slov Farm; 2008 Apr; 57(2):55-7. PubMed ID: 18578413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
    Portnoff JB; Cohen EM; Henley MW
    Bull Parenter Drug Assoc; 1977; 31(3):136-43. PubMed ID: 880416
    [No Abstract]   [Full Text] [Related]  

  • 18. [DATA ON THE DETERMINATION OF PARTICLE SIZE IN SUSPENSION OINTMENTS].
    LIUKSHENKOV AG; BLAGOVIDOVA IuA; LOGINTSEVA GA
    Aptechn Delo; 1963; 12():30-6. PubMed ID: 14072493
    [No Abstract]   [Full Text] [Related]  

  • 19. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
    Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
    N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacy compounding of an omeprazole suspension].
    Van Der Straeten F; Al-Afandi A; De Paepe K; Bovy J; Plaizier-Vercammen J
    J Pharm Belg; 2009 Jun; (2):54-63. PubMed ID: 19739529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.